Drug recall · January 15, 2020
Estriol, USP recall
Why: Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37
- Lots / codes
Lot Code/Exp. Date: 11061901, 11061803, 11281804, 11291804, 04171902, 05201901, 08121902, EXP 12/31/2020; 08161901, 10111903, EXP 5/31/2021; 11211904, 10161901, EXP 8/31/2021
- Quantity
- 42.12 gm
- Company
- Asclemed USA Inc. dba Enovachem Pharmaceuticals, Torrance, CA
- Distribution
- Product was distributed to 6 physician's offices within the state of California.
- Initiated
- December 9, 2019 · Voluntary: Firm initiated
- Classified
- January 8, 2020
- Reported
- January 15, 2020
- Ended
- August 9, 2023
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.